Artiva Biotherapeutics Chief Tech Operations Officer Christopher Horan Sells $43.6K of Stock
Christopher Horan, Chief Tech Operations Officer, sold 10,423 shares of Artiva Biotherapeutics, Inc. at $4.18 a share, worth $43.6K in total on Nov 2, 2026. Shares held after the trade: 302,321 (-3.3%).
Artiva Biotherapeutics COO, CLO, Compliance Officer Jennifer Bush Sells $35.3K of Stock
Jennifer Bush, COO, CLO, Compliance Officer, sold 8,439 shares of Artiva Biotherapeutics, Inc. at $4.18 a share, worth $35.3K in total on Nov 2, 2026. Shares held after the trade: 357,720 (-2.3%).
Artiva Biotherapeutics CEO Fred Aslan Sells $260K of Stock
Fred Aslan, CEO, sold 62,178 shares of Artiva Biotherapeutics, Inc. at $4.18 a share, worth $260K in total on Nov 2, 2026. Shares held after the trade: 1,457,428 (-4.1%).
Artiva Biotherapeutics CEO Fred Aslan Sells $169K of Stock
Fred Aslan, CEO, sold 23,463 shares of Artiva Biotherapeutics, Inc. at $7.20 a share, worth $169K in total on Oct 6, 2026. Shares held after the trade: 1,519,606 (-1.5%).
Artiva Biotherapeutics Chief Tech Operations Officer Christopher Horan Sells $70.7K of Stock
Christopher Horan, Chief Tech Operations Officer, sold 10,340 shares of Artiva Biotherapeutics, Inc. at $6.84 a share, worth $70.7K in total on Oct 5, 2026. Shares held after the trade: 312,744 (-3.2%).
Artiva Biotherapeutics COO, CLO, Compliance Officer Jennifer Bush Sells $57.2K of Stock
Jennifer Bush, COO, CLO, Compliance Officer, sold 8,370 shares of Artiva Biotherapeutics, Inc. at $6.84 a share, worth $57.2K in total on Oct 5, 2026. Shares held after the trade: 366,159 (-2.2%).
Artiva Biotherapeutics CEO Fred Aslan Sells $422K of Stock
Fred Aslan, CEO, sold 61,696 shares of Artiva Biotherapeutics, Inc. at $6.84 a share, worth $422K in total on Oct 5, 2026. Shares held after the trade: 1,543,069 (-3.8%).